| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.20B | +69.4% |
| Cost of Revenue | $194.2M | +57.1% |
| R&D Expense | $783.1M | -16.3% |
| SG&A Expense | $279.3M | -38.1% |
| Operating Income | $442.0M | +178.8% |
| Pre-tax Income | $528.7M | +209.0% |
| Income Tax | -$1.0M | -10.7% |
| Net Income | $529.7M | +209.4% |
| EPS (Basic) | $2.84 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $953.6M | +69.6% |
| Accounts Receivable | $590.2M | +68.8% |
| Current Assets | $3.14B | +41.0% |
| Total Assets | $3.24B | +38.6% |
| Current Liabilities | $271.3M | +54.1% |
| Total Liabilities | $310.1M | +50.7% |
| Stockholders' Equity | $2.93B | +37.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $690.9M | +211.1% |
| Capital Expenditures | $6.7M | +7.3% |
| Investing Cash Flow | -$218.9M | +50.3% |
| Financing Cash Flow | -$80.6M | -121.2% |
| Free Cash Flow | $684.2M | +217.0% |
| +185.3% |
| EPS (Diluted) | $2.62 | +178.7% |